PMID: 6397268Jan 1, 1984Paper

Monoclonal antibodies in the treatment of cancer

Critical Reviews in Oncology/hematology
R O Dillman

Abstract

Potential uses of monoclonal antibodies in anti-cancer treatment include passive serotherapy, radioisotope conjugates, toxin-linked conjugates, and chemotherapy-monoclonal antibody conjugates. The bases for these applications have been founded in research with heterologous antisera, and in some cases with monoclonal antibodies in animal tumor models. Human trials with passive serotherapy have already begun in both hematopoietic and solid tumor malignancies. Promising results have been reported in cutaneous T cell lymphoma with anti-T cell monoclonal antibody, and in nodular lymphoma with anti-idiotype monoclonal antibody. Radioisotope conjugate work appears promising for imaging in both animals and humans, and this work will lay the foundation for possible therapeutic application of radio-immunotherapy. Toxin-linked conjugates are promising in vitro and may have application in autologous bone marrow transplantation. Research with chemotherapy conjugates is also underway. Preliminary results suggest that murine monoclonal antibodies will be well tolerated clinically except in the setting of circulating cells which bear the target antigen, where rapid infusions may be associated with intolerable side effects. In certain diseases,...Continue Reading

References

Sep 15, 1978·JAMA : the Journal of the American Medical Association·M M Bortin, A A Rimm
Jul 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·H KoprowskiM Herlyn
Jun 1, 1978·Annals of Internal Medicine·R I FisherR C Young
Dec 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·R LevyR Warnke
Sep 13, 1979·The New England Journal of Medicine·E D ThomasP L Weiden
May 1, 1972·Cancer·T Ghose, S P Nigam
Sep 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·L Olsson, H S Kaplan
Jul 3, 1981·JAMA : the Journal of the American Medical Association·N JavadpourD M Goldenberg
Aug 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·D Herlyn, H Koprowski
Oct 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·E L ReinherzS F Schlossman
Jun 1, 1982·The Journal of Experimental Medicine·K A KrolickE S Vitetta
Aug 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·D G GillilandH Koprowski
Nov 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·J SchlomY A Teramoto
Oct 1, 1981·The Journal of Experimental Medicine·R S MetzgarB L Dowell
Sep 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·R J Youle, D M Neville
Dec 11, 1980·The New England Journal of Medicine·P H Black
Nov 19, 1981·Nature·I S Trowbridge
Mar 15, 1980·Cancer·E E KimD M Goldenberg

❮ Previous
Next ❯

Citations

Jun 1, 1987·Applied Biochemistry and Biotechnology·R J Linhardt
Jul 31, 1997·Breast Cancer : the Journal of the Japanese Breast Cancer Society·H IkegakiY Hashimoto
Jan 1, 1991·Pharmacology & Therapeutics·M Czuba, I C Smith
Jan 1, 1994·Biotechnology Advances·T Van Der Lende
Jun 5, 2012·Advanced Drug Delivery Reviews·Dana Litvak-Greenfeld, Itai Benhar
May 1, 1988·Seminars in Oncology Nursing·J B Dillman
Jan 1, 1987·Cancer Investigation·M C GlassyI Royston
Jun 30, 2015·Oncogene·E Flashner-AbramsonA Levitzki
Aug 1, 1987·Cancer·N H Bander
Jan 1, 1989·Journal of Toxicology and Environmental Health·G A Cabral, E M Mishkin
Mar 16, 1995·International Journal of Cancer. Journal International Du Cancer·D A Chow
Aug 1, 1997·Cancer Biotherapy & Radiopharmaceuticals·R O Dillman
Feb 1, 1994·Cancer Immunology, Immunotherapy : CII·L B ShihT C Hall
Apr 1, 1987·The Journal of Urology·N H Bander

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Related Papers

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
E Boven, H M Pinedo
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
S Y Chan, K Sikora
© 2021 Meta ULC. All rights reserved